Mathematical modelling of competitive LDL/VLDL binding and uptake by hepatocytes

T Pearson1, J A D Wattis, B O'Malley

  • 1Centre for Mathematical Medicine and Biology, School of Mathematical Sciences, University of Nottingham, University Park, Nottingham, UK. pmxtp@nottingham.ac.uk

Insights

Mathematical modeling reveals that Very Low-Density Lipoprotein (VLDL) particles outcompete Low-Density Lipoprotein (LDL) for cell surface receptors, impacting intracellular cholesterol levels. This competition influences how liver cells manage cholesterol, particularly under continuous lipoprotein delivery scenarios.

Area of Science:

  • Biochemistry
  • Mathematical Biology
  • Cell Biology

Background:

  • Elevated plasma low-density-lipoprotein cholesterol (LDL-C) is a key risk factor for coronary heart disease.
  • Hepatic uptake of LDL particles, primarily through receptor-mediated endocytosis, regulates plasma LDL-C levels.
  • Understanding lipoprotein-hepatocyte interactions is crucial for managing cardiovascular health.

Purpose of the Study:

  • To develop and analyze a mathematical model of LDL and VLDL particle binding and internalization by hepatocytes.
  • To investigate the impact of continuous lipoprotein delivery on intracellular cholesterol concentration.
  • To explore the competitive dynamics between LDL and VLDL for cell surface receptors.

Main Methods:

  • Formulation of a system of ordinary differential equations modeling lipoprotein uptake.
  • Inclusion of a cholesterol-dependent term for feedback regulation of surface receptors.
  • Numerical simulations and steady-state analysis to study model behavior.
  • Adaptation of the model for in vivo conditions with continuous lipoprotein delivery.

Main Results:

  • Model simulations show good agreement with in vitro LDL uptake data.
  • VLDL particles are predicted to outcompete LDL particles for receptor binding sites on hepatocytes.
  • Continuous delivery of low-level lipoproteins results in VLDL dominance at binding sites and a drop in intracellular cholesterol.
  • At high lipoprotein delivery rates, VLDL still outcompetes LDL, reaching maximum intracellular cholesterol levels more rapidly.

Conclusions:

  • The competition between VLDL and LDL for hepatocyte receptors significantly influences intracellular cholesterol dynamics.
  • VLDL's larger size and binding affinity give it a competitive advantage, affecting cholesterol homeostasis.
  • Model predictions offer insights for designing in vitro experiments and understanding in vivo lipoprotein metabolism.

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...